HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Thomas W. Rice Thomas J. Kirby Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rice, T. W. Articles by Kirby, T. J. Search for Related Content PubMed PubMed Citation Articles by Rice, T. W. Articles by Kirby, T. J.

Ann Thorac Surg 1992;53:972-977
© 1992 The Society of Thoracic Surgeons

---

Articles

Esophageal carcinoma: Esophageal ultrasound assessment of preoperative chemotherapy

^a Departments of Thoracic and Cardiovascular Surgery, Gastroenterology, and Hematology and Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio USA
^b Department of Gastroenterology, University of South Florida, Tampa, Florida USA

^_* Address reprint requests to Dr Rice, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195 USA.

The effect of preoperative chemotherapy in the treatment of esophageal carcinoma is difficult to assess because of the inadequacies of clinical staging. Endoscopic esophageal ultrasound (EUS) has been shown to be accurate in the clinical determination of depth of tumor invasion (T) and regional lymph node status (N). Therefore, EUS may be useful in assessing the effect of preoperative chemotherapy in the treatment of esophageal carcinoma. Eleven patients with operable adenocarcinoma of the esophagus or esophagogastric junction underwent staging by EUS before treatment. This was followed by two courses (10 patients) or one course (1 patient) of chemotherapy: etoposide, 120 mg/m² for 3 days; doxorubicin hydrochloride, 20 mg/m²; and cisplatin, 100 mg/m². Restaging by EUS was done after treatment. Ten patients then underwent resection of the tumor with lymphadenectomy. One patient was found to have metastatic disease at thoracotomy and did not undergo resection. However, tissue sampling was adequate for the determination of pathological stage. Independent pathological determinations of T and N were then obtained. On completion of chemotherapy, 9 patients (82%) had relief or reduction of preoperative symptoms, and 9 patients (82%) had either no evidence of tumor or reduction of tumor size by endoscopy. Despite this clinical and endoscopic response, no patient had EUS-documented and pathology-confirmed reduction of T. However, 2 patients had EUS-documented and pathology-confirmed progression of N. The accuracy of EUS in the determination of T was 82% and of N, 73%. We conclude that EUS offers a unique evaluation of the esophageal wall and adjacent tissue and is superior to symptomatic or endoscopic assessment of the effect of preoperative chemotherapy in the treatment of esophageal carcinoma.

This article has been cited by other articles:

				M. Westerterp, H. L. van Westreenen, J. B. Reitsma, O. S. Hoekstra, J. Stoker, P. Fockens, P. L. Jager, B. L. F. Van Eck-Smit, J. T. M. Plukker, J. J. B. van Lanschot, et al. Esophageal Cancer: CT, Endoscopic US, and FDG PET for Assessment of Response to Neoadjuvant Therapy--Systematic Review Radiology, September 1, 2005; 236(3): 841 - 851. [Abstract] [Full Text] [PDF]

				C. J. Lightdale and K. G. Kulkarni Role of Endoscopic Ultrasonography in the Staging and Follow-Up of Esophageal Cancer J. Clin. Oncol., July 10, 2005; 23(20): 4483 - 4489. [Abstract] [Full Text] [PDF]

				C. E. Reed General thoracic surgery and the Southern Thoracic Surgical Association: the second 25 years Ann. Thorac. Surg., November 1, 2003; 76(90050): S14 - 16. [Full Text] [PDF]

				T. W. Rice, E. H. Blackstone, D. J. Adelstein, G. Zuccaro Jr, J. J. Vargo, J. R. Goldblum, S. C. Murthy, M. M. DeCamp, and L. A. Rybicki Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1091 - 1102. [Abstract] [Full Text] [PDF]

				J. A. Hagen and T. R. DeMeester Esophageal adenocarcinoma Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432. [Full Text] [PDF]

				S. G. Urba, M. B. Orringer, A. Turrisi, M. Iannettoni, A. Forastiere, and M. Strawderman Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma J. Clin. Oncol., January 15, 2001; 19(2): 305 - 313. [Abstract] [Full Text] [PDF]

				N. M. Gupta and N. M. Gupta Transhiatal Versus Transthoracic Esophagectomy for Distal Esophageal Cancer Asian Cardiovasc Thorac Ann, December 1, 2000; 8(4): 347 - 352. [Abstract] [Full Text] [PDF]

				T. Lerut, W. Coosemans, P. De Leyn, D. Van Raemdonck, G. Deneffe, and G. Decker Treatment of Esophageal Carcinoma* Chest, December 1, 1999; 116(2011): 463S - 465S. [Abstract] [Full Text] [PDF]

				J. J. Nigro, S. R. DeMeester, J. A. Hagen, T. R. DeMeester, J. H. Peters, M. Kiyabu, G. M. R. Campos, S. Oberg, O. Gastal, P. F. Crookes, et al. NODE STATUS IN TRANSMURAL ESOPHAGEAL ADENOCARCINOMA AND OUTCOME AFTER EN BLOC ESOPHAGECTOMY J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 960 - 968. [Abstract] [Full Text] [PDF]

				J. F. Sabik, T. W. Rice, J. R. Goldblum, A. Koka, T. J. Kirby, S. V. Medendorp, and D. J. Adelstein Superficial esophageal carcinoma Ann. Thorac. Surg., October 1, 1995; 60(4): 896 - 902. [Abstract] [PDF]